FOR IMMEDIATE RELEASE

Contact: Amanda Drobnis at 480-477-0100

AniCell Biotech launches the BioScaff Surgical product line of regenerative therapies for horses and dogs.

Chandler, AZ, September 30, 2016 – At the American College of Veterinary Surgeons conference in Seattle, AniCell Biotech will be launching its BioScaff Surgical line of regenerative products for use in surgery as a bioscaffold for remodeling wounds. These amnion-based products contain all the naturally occurring, essential collagens, hyaluronic acids and proteins needed to facilitate tissue support after surgical procedures. From colic surgery to umbilical hernias to simple spays/neuters in dogs, these scaffolds provide all-natural wound support as a biological bandage and covers an assortment of wound types and sizes. The BioScaff line joins AniCell’s very successful acellular medical devices marketed under the EquusCell and CanisCell brands of Equine and Small Animal products. These products are derived from amnion collected non-invasively during the parturition of healthy baby foals and puppies.

“I used the AlloMatrix product on a 3 YO mare with a severed SDFT in a hind limb two months ago,” says Dr. Mark Haugland, DVM, DACVS. “I checked her yesterday and she was sound at the walk. The fetlock joint was not dropped as it was prior to injection. The tendon felt firm and I was unable to palpate the defect as I could before. So far I am impressed with the result